Celltrion is a South Korea-based pharmaceutical firm that develops and commercializes medicinal drugs for the treatment of diseases such as cancer and autoimmune.
Business Model:
Revenue: $1.7B
Employees: 1,001-5,000
Address: 23 Academy-ro
City: Incheon
State: gyeonggido
Zip: 406-840
Country: KR
Celltrion is a South Korea-based pharmaceutical firm that develops and commercializes medicinal drugs for the treatment of diseases such as cancer and autoimmune.
Contact Phone:
Contact Email:
Listed Exchange:
Korea Exchange
IPO Date:
7/29/2005
Ticker Symbol:
068270
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | Iksuda Therapeutics | Series A | 0 |
6/2021 | Iksuda Therapeutics | Series A | 0 |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|